Biogen BIIB Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) at other companies
Other financials
Where this comes from
Reported directly by Biogen in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour.
The official record: Biogen’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biogen's finite-lived intangible assets - expected amortization expense (year one).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biogen's finite-lived intangible assets - expected amortization expense (year one)?
- Biogen (BIIB) reported finite-lived intangible assets - expected amortization expense (year one) of $650M in Q1 2026.
- How has Biogen's finite-lived intangible assets - expected amortization expense (year one) changed year-over-year?
- Biogen's finite-lived intangible assets - expected amortization expense (year one) decreased by 2.3% year-over-year, from $665M to $650M.
- What is the long-term trend for Biogen's finite-lived intangible assets - expected amortization expense (year one)?
- Over 3 years (2020 to 2023), Biogen's finite-lived intangible assets - expected amortization expense (year one) has grown at a 28.7% compound annual growth rate (CAGR), from $225M to $480M.
- What does finite-lived intangible assets - expected amortization expense (year one) mean?
- This metric forecasts the amortization expense expected to be recognized in the upcoming fiscal year for intangible assets with finite useful lives. It provides visibility into the non-cash earnings impact of previously acquired intangible assets. Analysts use this to refine future earnings projections and cash flow models.